In addition to determining the relationship between BANCR and metabolic reprogramming, further exploration is needed to investigate the reasons for the downregulation of BANCR during the progression of ccRCC as well as its potential other functions in ccRCC invasion, migration, and resistance to targeted therapy or immunotherapy. The gene discussed is BANCR; the disease is nonpapillary renal cell carcinoma.